The Global Prader–Willi Syndrome Registry: Development, Launch, and Early Demographics
Open Access
Abstract
Advances in technologies offer new opportunities to collect and integrate data from a broad range of sources to advance the understanding of rare diseases and support the development of new treatments. Prader–Willi syndrome (PWS) is a rare, complex neurodevelopmental disorder, which has a variable and incompletely understood natural history. PWS is characterized by early failure to thrive, followed by the onset of excessive appetite (hyperphagia). Additional characteristics include multiple endocrine abnormalities, hypotonia, hypogonadism, sleep disturbances, a challenging neurobehavioral phenotype, and cognitive disability. The Foundation for Prader–Willi Research’s Global PWS Registry is one of more than twenty-five registries developed to date through the National Organization of Rare Disorders (NORD) IAMRARE Registry Program. The Registry consists of surveys covering general medical history, system-specific clinical complications, diet, medication and supplement use, as well as behavior, mental health, and social information. Information is primarily parent/caregiver entered. The platform is flexible and allows addition of new surveys, including updatable and longitudinal surveys. Launched in 2015, the PWS Registry has enrolled 1696 participants from 37 countries, with 23,550 surveys completed. This resource can improve the understanding of PWS natural history and support medical product development for PWS.Keywords
This publication has 27 references indexed in Scilit:
- A double‐blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndromeAmerican Journal of Medical Genetics Part A, 2014
- Psychiatric Illness and Intellectual Disability in the Prader–Willi Syndrome with Different Molecular Defects - A Meta AnalysisPLOS ONE, 2013
- Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2013
- RNAs of the human chromosome 15q11‐q13 imprinted regionWIREs RNA, 2012
- Prader-Willi syndromeGenetics in Medicine, 2012
- Psychiatric illness in a cohort of adults with Prader-Willi syndromeResearch in Developmental Disabilities, 2011
- Nutritional phases in Prader–Willi syndromeAmerican Journal of Medical Genetics Part A, 2011
- Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patientsOrphanet Journal of Rare Diseases, 2011
- Health Supervision for Children With Prader-Willi SyndromePediatrics, 2011
- Recommendations for the Diagnosis and Management of Prader-Willi SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2008